-/-mice die shortly after birth (Xu et al., 1996) . In that year, two studies used Traf3 -/-myeloid cells to show that TRAF3 was essential for induction of type I interferons (IFNs) in response to all the murine anti-viral nucleic acid sensing TLRs (TLR3, 7, 9), and also for TLR-independent type I IFN induction, whereas in contrast to TRAF6, there was no positive role for TRAF3 in NF-κB activation Häcker et al., 2006) . For TLRs, TRAF3 acted
in TNF receptor family signaling in B and T lymphocytes, and in pattern recognition receptor (PRR) signaling in antigen presenting cells, mainly through the use of gene deleted mice. For example, TRAF6 has been shown to be critical for signaling by two PRR families, namely the Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), where it controls activation of the transcription factor NF-κB, leading to the production of proinflammatory cytokines. However the function of TRAF3 remained enigmatic until 2006 since Traf3 -/-mice die shortly after birth (Xu et al., 1996) . In that year, two studies used Traf3 -/-myeloid cells to show that TRAF3 was essential for induction of type I interferons (IFNs) in response to all the murine anti-viral nucleic acid sensing TLRs (TLR3, 7, 9) , and also for TLR-independent type I IFN induction, whereas in contrast to TRAF6, there was no positive role for TRAF3 in NF-κB activation Häcker et al., 2006) . For TLRs, TRAF3 acted downstream of the TLR signaling proteins TRIF (for TLR3) and MyD88 and IRAK-4
(for TLR7 and 9), whereas TRAF3 acted in the RLR pathway downstream of the adaptor MAVS . Murine TRAF3 was also shown to negatively regulate the non-canonical NF-κB pathway in B cells, which involves processing of NF-κB p100 into NF-κB p52, and indeed constitutive activation of this pathway explained the postnatal lethality seen in Traf3 -/-mice is a positive regulator, resulting in the impaired production of some cytokines in R118W cells, whereas for the B cell activation factor receptor (BAFF-R) pathway, TRAF3 is a negative regulator (Figure 1 ). Similar to the situation in murine B cells, the noncanonical NF-κB pathway involving p100 processing into p52 was constitutively active due to impaired TRAF3 function (Figure 1 ). However, it is likely that the overall effects of impaired TRAF3 function on B cell signaling are more minor than that on the PRR pathways because complete defects in CD40 or BAFF-R signaling do have clinical consequences in terms of B cell expansion and function, whereas no such consequences seemed apparent for the TRAF3-deficient patient studied here.
In terms of human TRAF3 function, several questions remain. Although the authors argue that the role of TRAF3 in protection against HSE is due to TRAF3's involvement in the TLR3 pathway (Figure 1) , it is possible that there are alternative explanations for this. Certainly the TRAF3 deficiency mimics the previously reported TLR3 deficiency in terms of susceptibility to HSE (Zhang et al. 2007) , and indeed TLR3 is a PRR particularly expressed in the CNS. However, HSV-1 has been shown to be sensed by multiple PRRs in mice, and thus an alternative explanation for the essential role of TRAF3 in HSE protection in humans could be due to TLR3-independent roles for TRAF3 in PRR signaling (for example Figure 1(c) ). Then TLR3
and TRAF3 would both be independently necessary, but not sufficient, for protection against HSE. A further but related issue is, as in the case for TLR3, the narrow disease susceptibility arising from TRAF3 deficiency, especially given the prediction from murine and in vitro studies that TRAF3 is utilised by most PRRs for IFN induction. One explanation for this is that in humans the function of TRAF3 is redundant except for TLR3 signaling in the CNS, and that TLR3 is redundant in viral sensing except for neurotrophic viruses such as HSV-1. The exact mechanism by which TRAF3 (and TLR3) exert a protective effect against HSV-1 infection in the CNS is also unknown and requires further study. Further work will also be required to confirm that human TRAF3 is more important for NF-κB activation than for IRF3 activation, as this would be a crucial mouse-human difference. Overall, this study demonstrates the importance of TRAF3 for human host defense and provides mechanistic insights into how this important protein regulates human immune signaling. 
